Literature DB >> 8184045

Pulmonary sarcoidosis: role of CT in the evaluation of disease activity and functional impairment and in prognosis assessment.

M Remy-Jardin1, F Giraud, J Remy, L Wattinne, B Wallaert, A Duhamel.   

Abstract

PURPOSE: To investigate the role of computed tomography (CT) in determining disease activity and functional impairment and in predicting the prognosis of lung involvement in patients with sarcoidosis.
MATERIALS AND METHODS: Two groups of patients underwent CT, pulmonary function tests, and bronchoalveolar lavage. Disease activity was based on serum angiotensin converting enzyme activity and/or lymphocytosis at bronchoalveolar lavage. CT findings in group 1 were correlated with indexes of disease activity and functional parameters at diagnosis. In group 2, evaluation initially and at follow-up led to investigation of correlations between initial CT findings and evolution of disease activity and functional impairment.
RESULTS: CT abnormalities in group 1 were nodules, air-space consolidation, lung distortion, septal and nonseptal linear areas of high attenuation, ground-glass attenuation, and honeycombing. Profusion of septal lines was the only CT finding that correlated with disease activity. Statistically significant (P < .05) but low correlation (r < .48) was observed between the extent of abnormalities at CT and impairment of lung function, except for nodules.
CONCLUSION: Profusion of lung changes reflects functional impairment but not disease activity. CT findings cannot help predict the evolution of lung changes over time.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8184045     DOI: 10.1148/radiology.191.3.8184045

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  17 in total

Review 1.  Imaging of Sarcoidosis.

Authors:  Mario Silva; Hilario Nunes; Dominique Valeyre; Nicola Sverzellati
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

2.  Follow-up in pulmonary sarcoidosis: comparison between HRCT and pulmonary function tests.

Authors:  G Gafà; N Sverzellati; E Bonati; A Chetta; F Franco; E Rabaiotti; M De Filippo; E Marangio; D Figoli; T Meschi; M Zompatori; C Rossi
Journal:  Radiol Med       Date:  2012-05-14       Impact factor: 3.469

Review 3.  Sarcoidosis.

Authors:  D G Peckham; M A Spiteri
Journal:  Postgrad Med J       Date:  1996-04       Impact factor: 2.401

Review 4.  Respiratory medicine.

Authors:  R M du Bois
Journal:  BMJ       Date:  1995-06-17

Review 5.  Imaging aspects of the diagnosis of sarcoidosis.

Authors:  Paolo Spagnolo; Nicola Sverzellati; Athol U Wells; David M Hansell
Journal:  Eur Radiol       Date:  2014-01-08       Impact factor: 5.315

Review 6.  CT findings in severe thoracic sarcoidosis.

Authors:  Anne-Sophie Hennebicque; Hilario Nunes; Pierre-Yves Brillet; Hassen Moulahi; Dominique Valeyre; Michel W Brauner
Journal:  Eur Radiol       Date:  2004-09-24       Impact factor: 5.315

7.  Sarcoidosis-associated pulmonary hypertension: Clinical features and outcomes in Arab patients.

Authors:  Esam H Alhamad; Majdy M Idrees; Mohammed O Alanezi; Ahmad A Alboukai; Shaffi Ahmad Shaik
Journal:  Ann Thorac Med       Date:  2010-04       Impact factor: 2.219

8.  Outcome measures of the 6 minute walk test: relationships with physiologic and computed tomography findings in patients with sarcoidosis.

Authors:  Esam H Alhamad; Shaffi Ahmad Shaik; Majdy M Idrees; Mohammed O Alanezi; Arthur C Isnani
Journal:  BMC Pulm Med       Date:  2010-08-09       Impact factor: 3.317

Review 9.  Obstructive sarcoidosis.

Authors:  Petey Laohaburanakit; Andrew Chan
Journal:  Clin Rev Allergy Immunol       Date:  2003-10       Impact factor: 8.667

10.  Values of high-resolution computed tomography and pulmonary function tests in managements of patients with chronic hepatitis C virus infection.

Authors:  Oguzhan Okutan; Zafer Kartaloglu; Ahmet Ilvan; Ali Kutlu; Erkan Bozkanat; Emir Silit
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.